Skip to content

AIM Market Roundup: Microlise, Block Energy, ImmuPharma

AIM Market Roundup: Microlise, Block Energy, ImmuPharma

London’s AIM All Share index has shaken off the downbeat start to the week and is finding some support. Investors globally appear ready to look past yesterday’s mini rout but short term volatility at a stock or sector specific level may persist. At 3.30pm the index was three and a half points up at 714.91.

  • Microlise +27%
  • Block Energy +23%
  • ImmuPharma +21%
  • Tertiary Minerals -19%
  • Fiinu -18%

Microlise LON:SAAS was the biggest riser, up 27% at our early copy time. A full year trading update this morning noted a strong performance with adjusted EBITDA and net cash both well ahead of market expectations.


Block Energy LON:BLOE was in second place, some 23% up at 3pm. There’s been no formal news for some time but yesterday did see an uptick in volumes and selling pressure. It looks as if there may be some eyeing a bargain at this point although the spread is being quoted at around 13%.

ImmuPharma LON:IMM gets the notable mention, up 21% on the day. Shares had a good start to the year, advancing from around 1p to a mid-session high of more than 7p. Whilst some of that upside was off the back of the company’s participation in a key conference, support has been maintained to such an extent that management today issued a “speeding ticket” saying they had no explanation for the continued momentum. Shares have tipped back a little since.

Tertiary Minerals LON:TYM was the biggest faller, off 19%. The company published full year results and these have received a less than positive response, adding to the downside that has been in play since last week’s silver discovery announcement.

Fiinu LON:BANK was in second to last place, down 18%. The stock continues to give back some gains following the white label agreement announcement but still trades up more than 10x from levels seen at the start of the year.

Share this article

Invest with these platforms

Interactive Brokers eToro Charles Stanley Hargreaves Lansdown IG
Interactive Brokers eToro Charles Stanley

Looking for great investing ideas? Get our free newsletter

This article does not constitute investment advice.  Do your own research or consult a professional advisor.

Learn with our free 'How to' Guides

Our latest in-depth reports

On the podcast

Sign up for great investing stock tips

Thanks to our Site Partners

Our partners are established, regulated businesses and we are grateful for their support.

aberdeen
WisdomTree
Schroders
FP Markets

ARK
Pepperstone
eToro
CME Group

Back To Top